Back to Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

All insiders

8 insiders

InsiderRole% of sharesShares heldLast trade
Dube Michael PVP, Chief Accounting Officer0.05%69,527Mar 1, 2026
Clark ElianaEVP, Chief Technical Officer0.07%93,864Mar 2, 2026
Lebwohl DavidEVP, Chief Medical Officer0.09%131,192Mar 1, 2026
Schultes Birgit CEVP, Chief Scientific Officer0.10%137,733Mar 1, 2026
BASTA JAMESEVP, General Counsel0.11%156,794Mar 2, 2026
Dulac Edward J IIIEVP, Chief Financial Officer0.11%160,963Mar 1, 2026
Cohen Fred EDirector0.15%216,653Jun 9, 2026
LEONARD JOHN MPresident and CEO · Director0.83%1,169,739Mar 1, 2026
← PrevPage 1 of 1Next →